Lin T, Al-Makki A, Shepler B. Tenapanor: A new treatment option for hyperphosphatemia in end stage kidney disease. J Pharm Pharm Sci [Internet]. 2022 Jan. 16 [cited 2025 Apr. 2];25:77-83. Available from: https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/32284